James C Yao (James Yao)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 13

Top Topics

Peritoneal Dialysis

Neuroendocrine Tumors

Patient Reported Outcomes

Top Venues

Journal of hepatocellular carcinoma

Endocrine-related cancer

Future oncology (London, England)

Hepatology (Baltimore, Md.)

This page only lists publications with an associated author ORCID identifier.

Publications

Shadi Chamseddine, Michael LaPelusa, Lianchun Xiao, Yehia I Mohamed, Sunyoung S Lee, Zishuo Ian Hu, Rikita I Hatia, Manal Hassan, James C Yao, Dan G Duda, Saumil Datar, Hesham M Amin, Ahmed O Kaseb
Plasma Growth Hormone as a Prognostic Biomarker to Durvalumab and Tremelimumab in Patients with Advanced Hepatocellular Carcinoma. Journal of hepatocellular carcinoma 11 (2024)
Shadi Chamseddine, Michael LaPelusa, Lianchun Xiao, Yehia I Mohamed, Sunyoung S Lee, Zishuo Ian Hu, Rikita I Hatia, Manal Hassan, James C Yao, Dan G Duda, Saumil Datar, Hesham M Amin, Ahmed O Kaseb
Plasma Growth Hormone as a Prognostic Biomarker to Durvalumab and Tremelimumab in Patients with Advanced Hepatocellular Carcinoma. Journal of hepatocellular carcinoma 11 (2024)
Igryl S Cordero-Hernandez, Alicia C Ross, Arvind N Dasari, Daniel M Halperin, Beth Chasen, James C Yao
Transformation of G1-G2 neuroendocrine tumors to neuroendocrine carcinomas following peptide receptor radionuclide therapy. Endocrine-related cancer 31 (4) (2024)
Igryl S Cordero-Hernandez, Alicia C Ross, Arvind N Dasari, Daniel M Halperin, Beth Chasen, James C Yao
Transformation of G1-G2 neuroendocrine tumors to neuroendocrine carcinomas following peptide receptor radionuclide therapy. Endocrine-related cancer 31 (4) (2024)
Shadi Chamseddine, Michael LaPelusa, Lianchun Xiao, Yehia I Mohamed, Sunyoung S Lee, Zishuo Ian Hu, Rikita I Hatia, Manal Hassan, James C Yao, Dan G Duda, Saumil Datar, Hesham M Amin, Ahmed O Kaseb
Plasma Growth Hormone as a Prognostic Biomarker to Durvalumab and Tremelimumab in Patients with Advanced Hepatocellular Carcinoma. Journal of hepatocellular carcinoma 11 (2024)
Travis J Osterman, James C Yao, Monika K Krzyzanowska
Implementing Innovation: Informatics-Based Technologies to Improve Care Delivery and Clinical Research. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting 43 (2023)
Pamela L Kunz, Noah T Graham, Paul J Catalano, Halla S Nimeiri, George A Fisher, Teri A Longacre, Carlos J Suarez, Brock A Martin, James C Yao, Matthew H Kulke, Andrew E Hendifar, James C Shanks, Manisha H Shah, Mark M Zalupski, Edmond L Schmulbach, Diane L Reidy, Jonathan R Strosberg, Peter J O'Dwyer, Al Bowen Benson
A Randomized Study of Temozolomide or Temozolomide and Capecitabine in Patients with Advanced Pancreatic Neuroendocrine Tumors (ECOG-ACRIN E2211). Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
James C Yao, Emily Bergsland, Rahul Aggarwal, Ana Aparicio, Himisha Beltran, Judy S Crabtree, Christine L Hann, Toni Ibrahim, Lauren A Byers, Hironobu Sasano, John Umejiego, Marianne Pavel
DLL3 as an Emerging Target for the Treatment of Neuroendocrine Neoplasms. The oncologist 27 (11) (2022)
Ahmed Omar Kaseb, S Cheenu Kappadath, Sunyoung S Lee, Kanwal Pratap Raghav, Yehia I Mohamed, Lianchun Xiao, Jeffrey S Morris, Chimela Ohaji, Rony Avritscher, Bruno C Odisio, Joshua Kuban, Mohamed E Abdelsalam, Beth Chasen, Khaled M Elsayes, Mohamed Elbanan, Robert A Wolff, James C Yao, Armeen Mahvash
A Prospective Phase II Study of Safety and Efficacy of Sorafenib Followed by 90Y Glass Microspheres for Patients with Advanced or Metastatic Hepatocellular Carcinoma. Journal of hepatocellular carcinoma 8 (2021)
Arvind Dasari, Alberto F Sobrero, James C Yao, Takayuki Yoshino, William Schelman, Zhao Yang, Caly Chien, Marek Kania, Josep Tabernero, Cathy Eng
FRESCO-2: a global Phase III study investigating the efficacy and safety of fruquintinib in metastatic colorectal cancer. Future oncology (London, England) 17 (24) (2021)
Ya Chen Tina Shih, Ya-Chen Tina Shih, Hui Zhao, Deborah Schrag, James C Yao
Financial Burden of Discarded Weight-based Antineoplastic Drugs to Payers and Patients in the Private Insurance Market. JNCI cancer spectrum 5 (4) (2021)
Rodney John Hicks, Clarisse Dromain, Wouter W de Herder, Frederico P Costa, Christophe M Deroose, Andrea Frilling, Anna Koumarianou, Eric P Krenning, Eric Raymond, Lisa Bodei, Halfdan Sorbye, Staffan Welin, Bertram Wiedenmann, Damian Wild, James R Howe, James C Yao, Dermot O'Toole, Anders Sundin, Vikas Prasad
ENETS standardized (synoptic) reporting for molecular imaging studies in neuroendocrine tumours. Journal of neuroendocrinology (2021)
Jeffrey S Morris, Manal M Hassan, Ye Emma Zohner, Zeya Wang, Lianchun Xiao, Asif Rashid, Abedul Haque, Reham Abdel-Wahab, Yehia I Mohamed, Karri L Ballard, Robert A Wolff, Bhawana George, Liang Li, Genevera Allen, Michael Weylandt, Donghui Li, Wenyi Wang, Kanwal Raghav, James C Yao, Hesham M Amin, Ahmed Omar Kaseb
HepatoScore-14: Measures of Biological Heterogeneity Significantly Improve Prediction of Hepatocellular Carcinoma Risk. Hepatology (Baltimore, Md.) 73 (6) (2021)